Details for Patent: 4,658,021
✉ Email this page to a colleague
Summary for Patent: 4,658,021
Title: | Methionyl human growth hormone |
Abstract: | Described are methods and means for the construction and microbial expression of quasi-synthetic genes arising from the combination of organic synthesis and enzymatic reverse transcription from messenger RNA sequences incomplete from the standpoint of the desired protein product. Preferred products of expression lack bio-inactivating leader sequences common in eukaryotic expression products but problematic with regard to microbial cleavage to yield bioactive material. Illustrative is a preferred embodiment in which a gene coding for human growth hormone (useful in, e.g., treatment of hypopituitary dwarfism) is constructed and expressed. |
Inventor(s): | Goeddel; David V. (Burlingame, CA), Heyneker; Herbert L. (Burlingame, CA) |
Assignee: | Genentech, Inc. (So. San Francisco, CA) |
Application Number: | 06/654,340 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 4,658,021
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,658,021
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 244341 | ⤷ Try a Trial | |||
Austria | 112802 | ⤷ Try a Trial | |||
Austria | 232237 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |